Research Article
The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant
Table 2
The clinical manifestations and virological features of C/D recombinant.
| Items | Statistical description percentage (amount)/median (interquartile range) | Statistical value | value | C/D recombinant infected patients () | All patients () |
| Ethnicity | Tibetan 66.67% () Han 33.33 () | Tibetan 5.14% () Han 94.86% () | Fisher | <0.001 | Gender | Male 77.78% () Female 22.22% () | Male 81.87% () Female 18.13% () | = 0.000 | 1 | Age | 40 (22.5) | 33.50 (15) | | 0.388 | Alcohol | Alcohol-abuse 44.44% () Alcohol-free 55.56% () | Alcohol-abuse 82.48% () Alcohol-free 17.52% () | = 6.0651 | 0.01379 | Family history | Positive 77.78% () Negative 22.22% () | Positive 39.58% () Negative 60.42% () | = 3.8364 | 0.05015 | ALT (IU/L) | 38 (32) | 40 (42) | | 0.328 | TB (umol/L) | 11.50 (7.41) | 12.40 (9.44) | | 0.542 | ALB (g/L) | 47.50 (9.10) | 50.80 (22.40) | | 0.278 | ALP (IU/L) | 79 (33.25) | 91 (42.25) | | 0.228 | GGT (IU/L) | 45.50 (34.50) | 46 (54) | | 0.962 | AFP (ng/mL) | 3.55 (6.27) | 3.42 (3.54) | | 0.944 | HBeAg | Positive 77.78% () Negative 22.22% () | Positive 68.28% () Negative 31.72% () | = 0.058456 | 0.809 | log10 HBVDNA (IU/mL) | 6.69 (1.62) | 7.27 (3.04) | | 0.26 | BCP mutation | A1762T/G1764A 44.44% () G1896A 11.11% () A1762T/G1764A/G1896A 11.11% () Not detected 33.33% () | A1762T/G1764A 16.01% () G1896A 18.13% () A1762T/G1764A/G1896A 3.02% () Others 3.02% () Not detected 59.82% () | Fisher | 0.03049 | Fibroscan (Kpa) | 11.5 (8.55) | 7.95 (6.42) | | 0.921 |
|
|